The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.

The symposium was held October 27 at the 2016 Union World Conference on Lung Health in Liverpool, UK.

>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response.

Cutting-edge science and research are critical to developing new tools to catalyze the end of tuberculosis (TB).  The US government plays a vital role in advancing research and development (R&D) for TB, as it is the largest supporter of TB R&D globally. Yet years of flat US government funding for TB R&D have eroded the prospect of new tests, treatments, and a vaccine to combat the rising threat of drug-resistant TB. Urgent advocacy and action are needed to maintain and increase US government funding for TB R&D.

Treatment Action Group’s Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose shows that the world spent US$620.6 million on TB research and development in 2015, the lowest level of funding since 2008.

The petition will be delivered to the BRICS Ministers of Health on 14 November 2016, prior to their meeting in December in New Delhi.

The guide provides a brief summary of safety and efficacy data for the drugs currently in use for TB, and suggests advocacy points for activists.

"Stop Double Standards: From prevention through cure to ZERO TB" is a symposium organized by Treatment Action Group, Advanced Access & Delivery, Partners in Health, Harvard Medical School, and the Stop TB Partnership.

Join Treatment Action Group in calling for Prime Minister of India Narendra Modi to fix his government’s #brokenTBpromises.

Latest annual review on HIV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.